Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 12 matching records
THE FOOD AND DRUG ADMINISTRATION?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) BIOLOGICS EFFECTIVENESS AND SAFETY INNOVATIVE METHODS (BEST IM) PROGRAM ENHANCES THE SAFETY…Department of Health and Human Services$517.6K obligationsEnds Mar 29, 2028
TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CONTRACEPTIVE CLINICAL TRIALS NETWORK ACTIVITIES.Department of Health and Human Services$70.8K obligationsEnds Jul 31, 2027
OPERATION OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS FOR NIAIDDepartment of Health and Human Services$7.8M obligationsEnds Jun 30, 2028
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL TO EVALUATE THE ANTIVIRAL ACTIVITY, SAFETY, AND PHARMACOKINETICS OF NOVARTIS EYU688 AGAINST DENGUE VIRUS 2…Department of Health and Human Services$4.6M obligationsEnds Jul 22, 2026
PHASE I STUDY OF THE INFECTIVITY, SAFETY AND IMMUNOGENICITY OF TWO RECOMBINANT, LIVE-ATTENUATED, BOVINE/HUMAN, PARAINFLUENZA VIRUS TYPE 3 (B/HPIV3) VECTOR VACCINES EXPRESSING THE…Department of Health and Human Services$3.6M obligationsEnds Jun 30, 2028
EARLY MARKERS OF ALZHEIMER'S DISEASE PET IMAGING IN THE BLSADepartment of Health and Human Services$1.3M obligationsEnds Sep 28, 2022
JHU LYMEX DIAGNOSTICS PRIZE AND "LYMEX DXD" PILOT SCIENTIFIC ADVISING AND TECHNICAL ASSISTANCEDepartment of Health and Human Services$250.0K obligationsEnds Sep 22, 2025
75N94020D00017/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - JOHNS HOPKINS UNIVERSITY - FY22 CAN 8054183Department of Health and Human Services$93.7K obligationsEnds Jul 31, 2025
PHASE I STUDY OF THE INFECTIVITY, SAFETY AND IMMUNOGENICITY OF A RECOMBINANT, LIVE-ATTENUATED, BOVINE/HUMAN, PARAINFLUENZA VIRUS TYPE 3 (B/HPIV3) VECTOR VACCINE EXPRESSING THE…Department of Health and Human Services$100.6K obligationsEnds Sep 30, 2024
75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #001 RSV; POP 9/5/19-6/30/21; EVALUATION OF LIVE ATTENUATED PEDIATRIC RSV VACCINES FOR FISCAL YEAR (FY) 2019 RSV SEASONDepartment of Health and Human Services$12.8M obligationsEnds Mar 31, 2025
THE CONTRACTOR SHALL PERFORM A PHASE I CLINICAL STUDY TO EVALUATE INFECTIVITY, SAFETY, AND IMMUNOGENICITY OF A SINGLE INTRANASAL DOSE OF THE RECOMBINANT LIVE-ATTENUATED RSV…Department of Health and Human Services$4.1M obligationsEnds Sep 30, 2025
75N93019D00031; JOHNS HOPKINS UNIVERSITY; FY19; TO #002; POP 9/5/19-5/4/21Department of Health and Human Services$5.8M obligationsEnds Nov 30, 2024